Stocks
Amylyx Pharmaceuticals (AMLX) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -83.3% | -50.7% | 9.52% | -155.8% | -43.5% | -51.1% | ||
| Changes by years, y/y, % | +217pp | +33pp | +60pp | -165pp | +112pp | -32.0% | |||
Amylyx Pharmaceuticals. ROA, %
Amylyx Pharmaceuticals. ROA, changes, pp
Amylyx Pharmaceuticals (AMLX) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | -99.6% | -96.4% | -41.2% | -43.5% | -51.1% | -51.1% | |
| Changes by years, y/y, % | -83pp | -46pp | +62pp | +112pp | +48pp | |||
| Changes by quarters, q/q, % | +56pp | +3pp | +55pp | -2pp | -8pp | |||
